Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Aerovate Therapeutics, Inc. (AVTE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/11/2023 |
3
| Dable Habib J (Director) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 03/08/2023 |
3
| Pigot Timothy (Chief Commercial Officer) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 01/23/2023 |
3
| Santel Donald J (Director) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 03/23/2022 |
3
| Verwijs Marinus (Senior Vice President, CMC) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 07/19/2021 |
3
| Dorval Allison (Director) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 06/29/2021 |
3
| Atlas Venture Fund XII, L.P. (10% Owner) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 06/29/2021 |
3
| GRAYZEL DAVID S. (Director) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 06/29/2021 |
3
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 06/29/2021 |
3
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 06/29/2021 |
3
| Katabi Maha (10% Owner) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 06/29/2021 |
3
| NIVEN RALPH (Chief Development Officer) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 06/29/2021 |
3
| NOYES TIMOTHY P (CEO) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 06/29/2021 |
3
| Iwicki Mark T (Director) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 06/29/2021 |
3
| Resnick Joshua (Director) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 06/29/2021 |
3
| Gillies Hunter (Chief Medical Officer) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 06/29/2021 |
3
| Eldridge George A (See Remarks) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 06/29/2021 |
3
| Dake Benjamin T (See Remarks) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 06/29/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Aerovate Therapeutics, Inc. |
|
|